在中枢神经系统中增强氧胺活性剂的生物利用性的策略
Eliska Prchalova1, Zuzana Kohoutova1, Karolina Knittelova1
1Faculty of Science, Department of Chemistry, University of Hradec Kralove, Rokitanskeho 62, 500 03, Hradec Kralove, Czech Republic.
Archives of toxicology
|August 29, 2023
概括
纳米颗粒通过改善中枢神经系统 (CNS) 传递来增强对有机酸盐中毒治疗的氧化反应器. 这克服了氧化物穿越血脑屏障 (BBB) 的局限性,提供了一个有前途的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
- 纳米技术 纳米技术
背景情况:
- 有机中毒需要乙胆酶活性剂 (oximes).
- 氧化物因水友性而难以穿越血脑屏障 (BBB),限制了中枢神经系统的有效性.
- 有效的中枢神经系统 (CNS) 传递对于治疗严重中毒至关重要.
研究的目的:
- 审查在中枢神经系统中增强氧胺活性剂生物利用性的策略.
- 对氧化物进行基于纳米粒子的传递系统进行批判性讨论.
主要方法:
- 对各种交付策略的文献综述.
- 对纳米粒子配方的分析 (例如,二氧化,PLGA,脂质体).
- 讨论纳米反应器概念,结合生物清除器和氧化物.
主要成果:
- 纳米粒子显示出克服BBB限制的希望.
- 多种NP平台显示了中枢神经系统药物输送的潜力.
- 纳米反应器提供了联合排毒和重新激活.
结论:
- 纳米粒子输送系统代表了氧化物反应器的重大进步.
- 向中枢神经系统提供有针对性的药物是有效治疗有机中毒的关键.
- 对NP配方的进一步研究可以优化治疗结果.
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
1.0K
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.0K
Preparation of Amines: Reduction of Oximes and Nitro Compounds
3.7K
Oximes can be reduced to primary amines using catalytic hydrogenation, hydride reduction, or sodium metal reduction. The reduction of aliphatic and aromatic nitro compounds to primary amines takes place by either catalytic hydrogenation or by using active metals like Fe, Zn, and Sn in the presence of an acid.
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
3.7K
Drug Delivery: Parenteral Route
608
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
608
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.3K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.3K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
151
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
151
Adrenergic Agonists: Indirect-Acting Agents
1.7K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.7K


![Solid-phase Synthesis of [4.4] Spirocyclic Oximes](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58508.jpg&w=3840&q=50)